Comerica Securities’s DexCom DXCM Stock Holding History

Comerica Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$706K	Sell	7,570 -955	-11%	-$108K	0.06%	233
2023 Q2	$1.1M	Sell	8,525 -311	-4%	-$37.6K	0.08%	219
2023 Q1	$1.03M	Sell	8,836 -822	-9%	-$92K	0.07%	220
2022 Q4	$1.09M	Sell	9,658 -161	-2%	-$17.7K	0.08%	218
2022 Q3	$791K	Sell	9,819 -150	-2%	-$12.7K	0.07%	229
2022 Q2	$743K	Buy	9,969 +1,149	+13%	+$105K	0.06%	261
2022 Q1	$1.13M	Buy	8,820 +1,064	+14%	+$116K	0.08%	212
2021 Q4	$1.04M	Sell	7,756 -40	-0.5%	-$5.75K	0.07%	230
2021 Q3	$1.07M	Sell	7,796 -524	-6%	-$66.1K	0.08%	218
2021 Q2	$888K	Buy	+8,320	New	+$799K	0.07%	236

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Comerica Securities's DXCM Position: Q3 2023 in Review

Comerica Securities reduced its DexCom (DXCM) stake by 11% in Q3 2023, selling an estimated $108K and leaving 7,570 shares worth $706K. The position accounts for 0.06% of the portfolio, ranked #233.

Comerica Securities first reported a position in DXCM in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.13M in Q1 2022. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

Comerica Securities held 7,570 shares of DexCom worth $706K as of Q3 2023.
Comerica Securities sold 955 DexCom shares in Q3 2023, an estimated $108K.
DexCom made up 0.06% of Comerica Securities's portfolio in Q3 2023, its #233 holding.
Comerica Securities first reported a position in DexCom in Q2 2021 and has held it in 10 quarters since.
Comerica Securities's DexCom position peaked at $1.13M in Q1 2022.
903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.